Skip to content
Pre-order€2.97/day
--days
--hrs
--mins
--secs
Healthy7
Shop Now

Science

All studies and evidence

A complete overview of the human studies, reviews and clinical evidence behind the 7 pillars of Healthy7. Explore how each ingredient and benefit is supported by scientific research.

Every publication in this selection, with its participants, study type and source.
#Ingredient / TopicStudy titleYearParticipantsStudy typeFindingsSource
1Curcuma / curcumineNAFLD - serumlipiden, urinezuur en metabole markers2016-RCTPositivePubMed(opens in a new tab)
2Curcuma / curcumineNAFLD - levervet, ALT/AST en metabole uitkomsten2016-RCT · placeboPositivePubMed(opens in a new tab)
3Curcuma / curcumineNAFLD - inflammatoire markers na curcuminesuppletie201950RCTPositivePubMed(opens in a new tab)
4Curcuma / curcumineMetabool syndroom - curcumine/CoQ10 en cardiometabole markers2022882×2 RCTPositivePubMed(opens in a new tab)
5Curcuma / curcumineNAFLD - turmeric en lever-/metabole parameters202246RCTPositivePubMed(opens in a new tab)
6Curcuma / curcumineNAFLD - curcuminoïden en inflammatoire status202055RCTPositivePubMed(opens in a new tab)
7Curcuma / curcumineNAFLD - curcumine + piperine en lever/metabole uitkomsten202279RCTPositivePubMed(opens in a new tab)
8Curcuma / curcumineNAFLD - phytosomale curcumine en levervet/ALT/AST2017102RCT · placeboPositivePubMed(opens in a new tab)
9Curcuma / curcumineNAFLD - curcumin phytosome en lever-/metabole parameters202180RCTPositivePubMed(opens in a new tab)
10Curcuma / curcumineMetabool syndroom - nano-curcumine en metabole/inflammatoire markers202150RCTPositivePubMed(opens in a new tab)
11Curcuma / curcumineNAFLD - phytosomale curcumine, adiponectine en leptine201965RCTPositivePubMed(opens in a new tab)
12Curcuma / curcumineNAFLD - curcumine en epigenetische/DNA-schademarkers202054RCTPositivePubMed(opens in a new tab)
13Curcuma / curcumineHemodialyse - curcumine en oxidatieve stress/inflammatie202143RCTPositivePubMed(opens in a new tab)
14Curcuma / curcumineHemodialyse - turmeric ± piperine en oxidatieve stress2022-RCTPositivePubMed(opens in a new tab)
15Curcuma / curcumineHemodialyse - curcumine en inflammatoire/oxidatieve markers202228RCT / secundaire analysePositivePubMed(opens in a new tab)
16Curcuma / curcumineHemodialyse - nano-curcumine en inflammatoire biomarkers202154RCTPositivePubMed(opens in a new tab)
17Curcuma / curcuminePeritoneale dialyse - curcumine en oxidatieve/inflammatoire markers202448RCTPositivePubMed(opens in a new tab)
18Curcuma / curcumineEindstadium nierfalen - turmeric en oxidatieve stress201450RCTPositivePubMed(opens in a new tab)
19Curcuma / curcuminePCOS - curcumine, oxidatieve stress en SIRT1/PGC-1α202072RCTPositivePubMed(opens in a new tab)
20Curcuma / curcuminePCOS - curcumine, gewicht, glycemie en lipiden202060RCTPositivePubMed(opens in a new tab)
21Curcuma / curcumineMigraine - curcumine en inflammatoire biomarkers2022-RCTPositivePubMed(opens in a new tab)
22Curcuma / curcumineMigraine - omega-3 + nano-curcumine en inflammatie202080RCTPositivePubMed(opens in a new tab)
23Curcuma / curcumineGezonde volwassenen - curcumine en endotheliale functie201739RCTPositivePubMed(opens in a new tab)
24Curcuma / curcumineGezonde volwassenen - curcumine en vasculaire/endotheliale functie201659RCTPositivePubMed(opens in a new tab)
25Curcuma / curcumineCoronaire angioplastie - nano-curcumine en inflammatoire/oxidatieve markers202190RCTPositivePubMed(opens in a new tab)
26Curcuma / curcumineMetabool syndroom - curcumine en adipokines2016117RCTPositivePubMed(opens in a new tab)
27Curcuma / curcumineMetabool syndroom - curcumine en cytokines2016117RCT / post-hocPositivePubMed(opens in a new tab)
28Curcuma / curcumineObesitas - curcumine en pro-/anti-inflammatoire cytokines201430Crossover RCTPositivePubMed(opens in a new tab)
29Curcuma / curcumineAdolescente meisjes met overgewicht - curcumine en inflammatie/oxidatieve stress201960RCTPositivePubMed(opens in a new tab)
30Curcuma / curcumineType 2 diabetes + obesitas - curcumine, inflammatie en antioxidatieve capaciteit2026114RCTPositivePubMed(opens in a new tab)
31Curcuma / curcuminePost-COVID/vaccinatie - curcumine en inflammatoire markers202331RCTPositivePubMed(opens in a new tab)
32Curcuma / curcumineCOVID-19 - nano-curcumine en inflammatoire biomarkers202260RCTPositivePubMed(opens in a new tab)
33Curcuma / curcumineInspanning - curcumine en oxidatieve stress201310Crossover/interventiePositivePubMed(opens in a new tab)
34Curcuma / curcumineInspanning - curcumine, spierherstel en oxidatieve/inflammatoire respons201919RCTPositivePubMed(opens in a new tab)
35Curcuma / curcumineInspanning - Theracurmin en oxidatieve-stressmarkers202571RCTPositivePubMed(opens in a new tab)
36Curcuma / curcumineInspanning - hydrolyzed curcumin en herstel/oxidatieve stress202534RCTPositivePubMed(opens in a new tab)
37Curcuma / curcumineChemotherapie - curcumine en behandelingsgerelateerde toxiciteit/oxidatieve processen202280RCTPositivePubMed(opens in a new tab)
38Curcuma / curcumineSolide tumoren - curcuminoïden en systemische inflammatie201480RCTPositivePubMed(opens in a new tab)
39Curcuma / curcumineColitis ulcerosa - curcumine, ziekteactiviteit en inflammatie202070RCTPositivePubMed(opens in a new tab)
40Curcuma / curcumineColitis ulcerosa - curcumine + mesalazine en klinische/remissie-uitkomsten201550RCT · placeboPositivePubMed(opens in a new tab)

  • 1

    Positive

    NAFLD - serumlipiden, urinezuur en metabole markers

    Ingredient
    Curcuma / curcumine
    Year
    2016
    Participants
    -
    Study type
    RCT
    PubMed(opens in a new tab)

  • 2

    Positive

    NAFLD - levervet, ALT/AST en metabole uitkomsten

    Ingredient
    Curcuma / curcumine
    Year
    2016
    Participants
    -
    Study type
    RCT · placebo
    PubMed(opens in a new tab)

  • 3

    Positive

    NAFLD - inflammatoire markers na curcuminesuppletie

    Ingredient
    Curcuma / curcumine
    Year
    2019
    Participants
    50
    Study type
    RCT
    PubMed(opens in a new tab)

  • 4

    Positive

    Metabool syndroom - curcumine/CoQ10 en cardiometabole markers

    Ingredient
    Curcuma / curcumine
    Year
    2022
    Participants
    88
    Study type
    2×2 RCT
    PubMed(opens in a new tab)

  • 5

    Positive

    NAFLD - turmeric en lever-/metabole parameters

    Ingredient
    Curcuma / curcumine
    Year
    2022
    Participants
    46
    Study type
    RCT
    PubMed(opens in a new tab)

  • 6

    Positive

    NAFLD - curcuminoïden en inflammatoire status

    Ingredient
    Curcuma / curcumine
    Year
    2020
    Participants
    55
    Study type
    RCT
    PubMed(opens in a new tab)

  • 7

    Positive

    NAFLD - curcumine + piperine en lever/metabole uitkomsten

    Ingredient
    Curcuma / curcumine
    Year
    2022
    Participants
    79
    Study type
    RCT
    PubMed(opens in a new tab)

  • 8

    Positive

    NAFLD - phytosomale curcumine en levervet/ALT/AST

    Ingredient
    Curcuma / curcumine
    Year
    2017
    Participants
    102
    Study type
    RCT · placebo
    PubMed(opens in a new tab)

  • 9

    Positive

    NAFLD - curcumin phytosome en lever-/metabole parameters

    Ingredient
    Curcuma / curcumine
    Year
    2021
    Participants
    80
    Study type
    RCT
    PubMed(opens in a new tab)

  • 10

    Positive

    Metabool syndroom - nano-curcumine en metabole/inflammatoire markers

    Ingredient
    Curcuma / curcumine
    Year
    2021
    Participants
    50
    Study type
    RCT
    PubMed(opens in a new tab)

  • 11

    Positive

    NAFLD - phytosomale curcumine, adiponectine en leptine

    Ingredient
    Curcuma / curcumine
    Year
    2019
    Participants
    65
    Study type
    RCT
    PubMed(opens in a new tab)

  • 12

    Positive

    NAFLD - curcumine en epigenetische/DNA-schademarkers

    Ingredient
    Curcuma / curcumine
    Year
    2020
    Participants
    54
    Study type
    RCT
    PubMed(opens in a new tab)

  • 13

    Positive

    Hemodialyse - curcumine en oxidatieve stress/inflammatie

    Ingredient
    Curcuma / curcumine
    Year
    2021
    Participants
    43
    Study type
    RCT
    PubMed(opens in a new tab)

  • 14

    Positive

    Hemodialyse - turmeric ± piperine en oxidatieve stress

    Ingredient
    Curcuma / curcumine
    Year
    2022
    Participants
    -
    Study type
    RCT
    PubMed(opens in a new tab)

  • 15

    Positive

    Hemodialyse - curcumine en inflammatoire/oxidatieve markers

    Ingredient
    Curcuma / curcumine
    Year
    2022
    Participants
    28
    Study type
    RCT / secundaire analyse
    PubMed(opens in a new tab)

  • 16

    Positive

    Hemodialyse - nano-curcumine en inflammatoire biomarkers

    Ingredient
    Curcuma / curcumine
    Year
    2021
    Participants
    54
    Study type
    RCT
    PubMed(opens in a new tab)

  • 17

    Positive

    Peritoneale dialyse - curcumine en oxidatieve/inflammatoire markers

    Ingredient
    Curcuma / curcumine
    Year
    2024
    Participants
    48
    Study type
    RCT
    PubMed(opens in a new tab)

  • 18

    Positive

    Eindstadium nierfalen - turmeric en oxidatieve stress

    Ingredient
    Curcuma / curcumine
    Year
    2014
    Participants
    50
    Study type
    RCT
    PubMed(opens in a new tab)

  • 19

    Positive

    PCOS - curcumine, oxidatieve stress en SIRT1/PGC-1α

    Ingredient
    Curcuma / curcumine
    Year
    2020
    Participants
    72
    Study type
    RCT
    PubMed(opens in a new tab)

  • 20

    Positive

    PCOS - curcumine, gewicht, glycemie en lipiden

    Ingredient
    Curcuma / curcumine
    Year
    2020
    Participants
    60
    Study type
    RCT
    PubMed(opens in a new tab)

  • 21

    Positive

    Migraine - curcumine en inflammatoire biomarkers

    Ingredient
    Curcuma / curcumine
    Year
    2022
    Participants
    -
    Study type
    RCT
    PubMed(opens in a new tab)

  • 22

    Positive

    Migraine - omega-3 + nano-curcumine en inflammatie

    Ingredient
    Curcuma / curcumine
    Year
    2020
    Participants
    80
    Study type
    RCT
    PubMed(opens in a new tab)

  • 23

    Positive

    Gezonde volwassenen - curcumine en endotheliale functie

    Ingredient
    Curcuma / curcumine
    Year
    2017
    Participants
    39
    Study type
    RCT
    PubMed(opens in a new tab)

  • 24

    Positive

    Gezonde volwassenen - curcumine en vasculaire/endotheliale functie

    Ingredient
    Curcuma / curcumine
    Year
    2016
    Participants
    59
    Study type
    RCT
    PubMed(opens in a new tab)

  • 25

    Positive

    Coronaire angioplastie - nano-curcumine en inflammatoire/oxidatieve markers

    Ingredient
    Curcuma / curcumine
    Year
    2021
    Participants
    90
    Study type
    RCT
    PubMed(opens in a new tab)

  • 26

    Positive

    Metabool syndroom - curcumine en adipokines

    Ingredient
    Curcuma / curcumine
    Year
    2016
    Participants
    117
    Study type
    RCT
    PubMed(opens in a new tab)

  • 27

    Positive

    Metabool syndroom - curcumine en cytokines

    Ingredient
    Curcuma / curcumine
    Year
    2016
    Participants
    117
    Study type
    RCT / post-hoc
    PubMed(opens in a new tab)

  • 28

    Positive

    Obesitas - curcumine en pro-/anti-inflammatoire cytokines

    Ingredient
    Curcuma / curcumine
    Year
    2014
    Participants
    30
    Study type
    Crossover RCT
    PubMed(opens in a new tab)

  • 29

    Positive

    Adolescente meisjes met overgewicht - curcumine en inflammatie/oxidatieve stress

    Ingredient
    Curcuma / curcumine
    Year
    2019
    Participants
    60
    Study type
    RCT
    PubMed(opens in a new tab)

  • 30

    Positive

    Type 2 diabetes + obesitas - curcumine, inflammatie en antioxidatieve capaciteit

    Ingredient
    Curcuma / curcumine
    Year
    2026
    Participants
    114
    Study type
    RCT
    PubMed(opens in a new tab)

  • 31

    Positive

    Post-COVID/vaccinatie - curcumine en inflammatoire markers

    Ingredient
    Curcuma / curcumine
    Year
    2023
    Participants
    31
    Study type
    RCT
    PubMed(opens in a new tab)

  • 32

    Positive

    COVID-19 - nano-curcumine en inflammatoire biomarkers

    Ingredient
    Curcuma / curcumine
    Year
    2022
    Participants
    60
    Study type
    RCT
    PubMed(opens in a new tab)

  • 33

    Positive

    Inspanning - curcumine en oxidatieve stress

    Ingredient
    Curcuma / curcumine
    Year
    2013
    Participants
    10
    Study type
    Crossover/interventie
    PubMed(opens in a new tab)

  • 34

    Positive

    Inspanning - curcumine, spierherstel en oxidatieve/inflammatoire respons

    Ingredient
    Curcuma / curcumine
    Year
    2019
    Participants
    19
    Study type
    RCT
    PubMed(opens in a new tab)

  • 35

    Positive

    Inspanning - Theracurmin en oxidatieve-stressmarkers

    Ingredient
    Curcuma / curcumine
    Year
    2025
    Participants
    71
    Study type
    RCT
    PubMed(opens in a new tab)

  • 36

    Positive

    Inspanning - hydrolyzed curcumin en herstel/oxidatieve stress

    Ingredient
    Curcuma / curcumine
    Year
    2025
    Participants
    34
    Study type
    RCT
    PubMed(opens in a new tab)

  • 37

    Positive

    Chemotherapie - curcumine en behandelingsgerelateerde toxiciteit/oxidatieve processen

    Ingredient
    Curcuma / curcumine
    Year
    2022
    Participants
    80
    Study type
    RCT
    PubMed(opens in a new tab)

  • 38

    Positive

    Solide tumoren - curcuminoïden en systemische inflammatie

    Ingredient
    Curcuma / curcumine
    Year
    2014
    Participants
    80
    Study type
    RCT
    PubMed(opens in a new tab)

  • 39

    Positive

    Colitis ulcerosa - curcumine, ziekteactiviteit en inflammatie

    Ingredient
    Curcuma / curcumine
    Year
    2020
    Participants
    70
    Study type
    RCT
    PubMed(opens in a new tab)

  • 40

    Positive

    Colitis ulcerosa - curcumine + mesalazine en klinische/remissie-uitkomsten

    Ingredient
    Curcuma / curcumine
    Year
    2015
    Participants
    50
    Study type
    RCT · placebo
    PubMed(opens in a new tab)

Showing 40 of 152 studies